Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...

Lenacapavir represents a paradigm shift in HIV prevention, offering a long-acting injectable option administered once every ...

Nigeria has recorded a major breakthrough in its fight against HIV with the arrival of the long-acting injectable drug, Lenacapavir, designed for HIV prevention.The National AIDS, Viral Hepatitis and ...

Nigeria’s fight against HIV and AIDS may be approaching a turning point with the introduction of Lenacapavir, a long-acting injectable drug that experts say could greatly reduce new infections.

The Minister of State for Health and Social Welfare, Iziaq Adekunle Salako, has announced the rollout of a groundbreaking long-acting HIV prevention drug, describing it as a major milestone in Nigeria ...

In a landmark move to strengthen the fight against HIV/AIDS, the Federal Government has introduced Lenacapavir, a long-acting injectable drug for HIV prevention administered once every six months.

The fight against HIV/AIDS in Nigeria got a boost with the introduction of twice-yearly injectable Lenacapavir (LEN) in eight states. The rollout, which will begin in Anambra, Ebonyi, Gombe, Kwara, ...

The Federal Government has announced plans to roll out a new long-acting HIV prevention injection, Lenacapavir, as part of ...

Background: Prevention programs often promote HIV testing as one possible strategy of combating the spread of the disease. Objective: To examine levels of HIV testing practices among a large sample of ...

Sustaining the achievements of the past two decades of global HIV programs and reaching the goal of ending HIV/AIDS as a public health threat by 2030 depend on dramatically reducing new infections.